[Radiotherapy-associated morbidity and mortality in rectal surgery]

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Rectal cancer treatment has advanced with improved radiotherapy and surgical techniques.
• Neoadjuvant treatment demonstrates benefits over adjuvant radiotherapy in large trials.
• Neoadjuvant irradiation enhances local tumor control in rectal cancer patients.

Purpose of the Study:

• To summarize evidence on neoadjuvant radiotherapy for rectal cancer.
• To review postoperative morbidity and mortality associated with neoadjuvant radiotherapy.
• To assess long-term chronic effects of neoadjuvant radiotherapy.

Main Methods:

• Review of available evidence on neoadjuvant radiotherapy in rectal cancer.
• Analysis of data regarding postoperative outcomes.
• Evaluation of long-term effects of radiation therapy.

Main Results:

• Neoadjuvant radiotherapy improves local tumor control.
• No survival advantage was observed with neoadjuvant radiotherapy plus total mesorectal excision versus surgery alone.
• Radiation therapy carries inherent morbidity and mortality risks.

Conclusions:

• Neoadjuvant radiotherapy is effective for local rectal cancer control.
• The survival benefit of neoadjuvant radiotherapy in conjunction with total mesorectal excision requires further investigation.
• Understanding and managing the morbidity and mortality of neoadjuvant radiotherapy are crucial for patient outcomes.